drugset / Trial / NCT03011177
Teneligliptin Versus Linagliptin in Diabetes Mellitus Type Two Patients
RandomizedParallel-groupOpen-labelTreatment
Summary
To assess the efficacy and safety of Teneligliptin and Linagliptin in the type 2 Diabetes Mellitus patients.
Timeline
- Start
- 2017-01
- Primary completion
- 2018-09
- Completion
- 2018-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Linagliptin | Small molecule | 5 mg | — |
| Subject | Teneligliptin | Small molecule | 20 mg | — |